Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Cash from Investing Activities (2023 - 2025)

Guardian Pharmacy Services' Cash from Investing Activities history spans 3 years, with the latest figure at -$4.7 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 28.89% year-over-year to -$4.7 million; the TTM value through Dec 2025 reached -$32.2 million, down 5.98%, while the annual FY2025 figure was -$32.2 million, 5.98% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$4.7 million at Guardian Pharmacy Services, up from -$9.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$1.1 million in Q4 2023 and bottomed at -$13.1 million in Q2 2024.
  • The 3-year median for Cash from Investing Activities is -$6.6 million (2024), against an average of -$7.1 million.
  • The largest annual shift saw Cash from Investing Activities crashed 477.51% in 2024 before it rose 28.89% in 2025.
  • A 3-year view of Cash from Investing Activities shows it stood at -$1.1 million in 2023, then plummeted by 477.51% to -$6.6 million in 2024, then grew by 28.89% to -$4.7 million in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Cash from Investing Activities are -$4.7 million (Q4 2025), -$9.0 million (Q3 2025), and -$13.0 million (Q2 2025).